Archive for June, 2010:

Myth of the innocent drug company

Wednesday 30 June 2010

Christoph Westphal is a very intelligent person, otherwise he would not have been granted an MD/PhD from Harvard and a BA (Phi Beta Kappa) from Colombia. And he wouldn’t have founded various biotech companies or been named to head GSK’s venture arm. Yet it doesn’t take someone with an advanced degree to realize something is wrong with his op-ed (The myth of the perfect drug) in yesterday’s Boston Globe.

(Continue reading…)

Almost 30 percent of adolescents take prescription drugs

Wednesday 19 May 2010

Prescription drug utilization among children increased 5 percent in 2009, according to the Medco 2010 Drug Trend Report. The growth rate was four times as high as the population overall.

(Continue reading…)

FDA: Flush it away

Saturday 17 October 2009

I went to a lecture the other night on risky behaviors of adolescents. The speakers including leading medical experts who work with teens. The main emphasis was on use/abuse of alcohol and marijuana. The speakers encouraged parents to lock up their liquor, for example.

(Continue reading…)

Avastin and Lucentis: When paying more is better

Saturday 3 October 2009

Genentech’s Lucentis for age-related macular degeneration is basically just a different name for Avastin, a cancer drug. From the New York Times (A Rule on Eye Treatment is Likely to Cost Millions)

(Continue reading…)

Happy 4th birthday to the Health Business Blog

Monday 9 March 2009

byear4.gif
The Health Business Blog is four years old with over 2000 posts. Continuing a tradition I established with birthdays one, two, and three, I’ve picked out a favorite post from each month.

(Continue reading…)